Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Mycobacterial nicotinate mononucleotide adenylyltransferase: Structure, mechanism, and implications for drug discovery

Journal Article · · Journal of Biological Chemistry
 [1];  [2];  [3];  [4];  [5];  [4];  [4];  [6];  [2];  [4]
  1. Sanford-Burnham Medical Research Institute, La Jolla, CA (United States); DOE Office of Scientific and Technical Information (OSTI)
  2. Vertex Pharmaceuticals Inc., Boston, MA (United States)
  3. Polytechnic Univ. of Marche, Ancona (Italy)
  4. Sanford-Burnham Medical Research Institute, La Jolla, CA (United States)
  5. Russian Academy of Sciences, Moscow (Russia)
  6. Harvard School of Public Health, Boston, MA (United States)

Nicotinate mononucleotide adenylyltransferase NadD is an essential enzyme in the biosynthesis of the NAD cofactor, which has been implicated as a target for developing new antimycobacterial therapies. Here we report the crystal structure of Mycobacterium tuberculosis NadD (MtNadD) at a resolution of 2.4 Å. A remarkable new feature of the MtNadD structure, compared with other members of this enzyme family, is a 310 helix that locks the active site in an over-closed conformation. As a result, MtNadD is rendered inactive as it is topologically incompatible with substrate binding and catalysis. Directed mutagenesis was also used to further dissect the structural elements that contribute to the interactions of the two MtNadD substrates, i.e. ATP and nicotinic acid mononucleotide (NaMN). For inhibitory profiling of partially active mutants and wild type MtNadD, we used a small molecule inhibitor of MtNadD with moderate affinity (Ki ~ 25 μM) and antimycobacterial activity (MIC80) ~ 40-80 μM). This analysis revealed interferences with some of the residues in the NaMN binding subsite consistent with the competitive inhibition observed for the NaMN substrate (but not ATP). A detailed steady-state kinetic analysis of MtNadD suggests that ATP must first bind to allow efficient NaMN binding and catalysis. This sequential mechanism is consistent with the requirement of transition to catalytically competent (open) conformation hypothesized from structural modeling. A possible physiological significance of this mechanism is to enable the down-regulation of NAD synthesis under ATP-limiting dormancy conditions. Lastly, these findings point to a possible new strategy for designing inhibitors that lock the enzyme in the inactive over-closed conformation.

Research Organization:
Univ. of California, Berkeley, CA (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1347693
Journal Information:
Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 12 Vol. 290; ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular BiologyCopyright Statement
Country of Publication:
United States
Language:
English

References (38)

WHO's 2013 global report on tuberculosis: successes, threats, and opportunities journal November 2013
Crystal Structures of E. coli Nicotinate Mononucleotide Adenylyltransferase and Its Complex with Deamido-NAD journal January 2002
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects journal April 2014
Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery journal September 2004
Targeting NAD Biosynthesis in Bacterial Pathogens: Structure-Based Development of Inhibitors of Nicotinate Mononucleotide Adenylyltransferase NadD journal August 2009
Characterization of bacterial NMN deamidase as a Ser/Lys hydrolase expands diversity of serine amidohydrolases journal February 2014
Crystal Structure of Nicotinic Acid Mononucleotide Adenylyltransferase from Pseudomonas aeruginosa in its Apo and Substrate-complexed Forms Reveals a Fully Open Conformation journal August 2005
Crystal Structure of Nicotinic Acid Mononucleotide Adenylyltransferase from Staphyloccocus aureus: Structural Basis for NaAD Interaction in Functional Dimer journal July 2006
Kinetic and X-Ray Structural Evidence for Negative Cooperativity in Substrate Binding to Nicotinate Mononucleotide Adenylyltransferase (NMAT) from Bacillus anthracis journal January 2009
The scent of Mycobacterium tuberculosis – Part II breath journal July 2009
Domain Organization and a Protease-Sensitive Loop in Eukaryotic Ornithine Decarboxylase journal October 1995
Initial-Rate Kinetics of Human NMN-Adenylyltransferases:  Substrate and Metal Ion Specificity, Inhibition by Products and Multisubstrate Analogues, and Isozyme Contributions to NAD + Biosynthesis journal April 2007
Complexes of Bacterial Nicotinate Mononucleotide Adenylyltransferase with Inhibitors: Implication for Structure-Based Drug Design and Improvement journal July 2010
Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism journal February 2014
Regulation of active site coupling in glutamine-dependent NAD+ synthetase journal March 2009
Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis journal February 2009
A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence journal November 2013
Identification, Characterization, and Crystal Structure of Bacillus subtilis Nicotinic Acid Mononucleotide Adenylyltransferase journal November 2001
Genomics-driven Reconstruction of Acinetobacter NAD Metabolism: INSIGHTS FOR ANTIBACTERIAL TARGET SELECTION journal October 2010
Identification of Nicotinamide Mononucleotide Deamidase of the Bacterial Pyridine Nucleotide Cycle Reveals a Novel Broadly Conserved Amidohydrolase Family journal September 2011
Subcellular Compartmentation and Differential Catalytic Properties of the Three Human Nicotinamide Mononucleotide Adenylyltransferase Isoforms journal August 2005
Biosynthesis and Recycling of Nicotinamide Cofactors in Mycobacterium tuberculosis: AN ESSENTIAL ROLE FOR NAD IN NONREPLICATING BACILLI journal May 2008
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Overview of the CCP 4 suite and current developments journal March 2011
REFMAC 5 for the refinement of macromolecular crystal structures journal March 2011
Data processing and analysis with the autoPROC toolbox journal March 2011
Mycobacterium tuberculosis : success through dormancy journal May 2012
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis journal January 2005
Glycerate 2-Kinase of Thermotoga maritima and Genomic Reconstruction of Related Metabolic Pathways journal December 2007
Quinolinate Salvage and Insights for Targeting NAD Biosynthesis in Group A Streptococci journal November 2012
Archaeal Shikimate Kinase, a New Member of the GHMP-Kinase Family journal January 2001
From Genetic Footprinting to Antimicrobial Drug Targets: Examples in Cofactor Biosynthetic Pathways journal August 2002
Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria journal February 2014
Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase journal August 2011
Glutamine versus Ammonia Utilization in the NAD Synthetase Family journal June 2012
Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis journal November 2008
Targeting Dormant Bacilli to Fight Tuberculosis journal January 2013

Cited By (3)

High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity journal September 2019
The Mycobacterium tuberculosis Pup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway journal February 2019
Molecular basis of human asparagine synthetase inhibitor specificity posted_content September 2018